Dr Robert Stevenson, Consultant Clinical Oncologist
Dr Robert Stevenson
Consultant Clinical Oncologist
Dr Robert Stevenson
Consultant Clinical Oncologist

Areas of expertise
- Cancer care
- Chemotherapy
- Cyberknife therapy
- Genetic testing
- Hormone therapy

Make an appointment
Address
-
The Harborne Hospital, part of HCA Healthcare UK
Mindelsohn Way, Birmingham, B15 2FQ
About Dr Robert Stevenson
GMC number: 6121110
Year qualified: 2005
Place of primary qualification: Leicester Warwick Medical School
Dr Robert Stevenson is a distinguished consultant oncologist at HCA Healthcare UK. He specialises in the treatment of various cancers, with a particular focus on breast and gastrointestinal malignancies. Dr Stevenson is committed to providing personalised care and employs the latest advancements in oncology to optimise patient outcomes.
Throughout his career, Dr Stevenson has been actively involved in clinical research, contributing to numerous publications in peer-reviewed journals. His dedication to advancing cancer treatment has led him to participate in several clinical trials, aiming to improve therapeutic strategies and patient quality of life.
In addition to his clinical and research responsibilities, Dr Stevenson is passionate about medical education. He regularly mentors medical students and junior doctors, sharing his extensive knowledge and experience to cultivate the next generation of healthcare professionals.
Outside of his professional commitments, Dr Stevenson has a keen interest in medical ethics and patient advocacy. He strives to ensure that patients are well-informed and actively involved in their treatment decisions, promoting a holistic approach to cancer care.
Dr Stevenson joined HCA Healthcare UK in 2015 and has since been an integral part of the oncology department. His compassionate approach and dedication to excellence have earned him recognition among colleagues and patients alike.
Areas of expertise
- Adenocarcinoma
- Advanced prostate cancer
- Bladder cancer
- Cancer care
- Cancer of unknown primary
- Carcinoma of unknown primary
- Chemotherapy
- Cyberknife therapy
- Genetic testing
- Hormone therapy
- Image guided radiotherapy (IGRT)
- Immunotherapy
- Intensity modulated radiotherapy (IMRT)
- Lung cancer
- Metastases
- MRI-linac radiotherapy
- Orthovoltage
- Penile cancer
- Photodynamic therapy (PDT)
- Prostate cancer
- Prostate cancer diagnostics
- Radiotherapy
- Rapidarc or volume modulated arc therapy (VMAT)
- Stereotactic ablative radiotherapy (SABR)
- Stereotactic radiosurgery (SRS)
- Superficial radiotherapy
- Targeted therapy
- Testicular cancer
- Urological cancers
Professional memberships




